FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereinafter FRONTEO) is the first judge in the United States to approve the use of TAR in the "Dasylva Moore Trial" by Andrew Peck. (Judge Andrew J. Peck, currently Senior Counselor, NY Office of DLA Piper) and Tony Andriotis (currently Tokyo Office Partner of DLA Piper), a joint seminar "Technology and Analytics in Cross-Border e-Discovery" We would like to inform you that we have held "Utilization".

Discovery as a method of collecting pretrial evidence in the U.S. civil proceedings and the process of digital forensics have a process called "review (viewing)", which is a review using AI or a computer (TAR: Technology Assisted Review) is used. By extracting only the data necessary for the proceedings from the huge amount of data collected by TAR, the amount of sentences to be reviewed can be reduced and the documents to be reviewed can be prioritized. For a company that is, it is possible to reduce the time and cost by 7% to 8% compared to the case where all the review work is done manually.Andrew Peck is widely known in the world as the first person in the world to approve the use of this TAR in a proceeding decision.

About Andrew Peck
Andrew Peck has been a Justice of the Peace for about 23 years at the United States District Court for the Southern District of New York, one of the most influential federal district courts in the United States. He has been active and is now a senior counselor for DLA Piper, leading the way as an e-discovery and litigation advisor.He has also worked extensively as a committee, mediator, arbitrator, and special member of the American Arbitration Association (AAA), and has been involved in eDiscovery at the Law Technology News (now LegalTech News) Champion of Technology Awards and over the last 50 years. Has won various awards, including being on the list of Top 50 Innovators.

At the joint seminar between FRONTEO and DLA Piper held on June 6, we will hear the valuable opinions of Andrew Peck and Tony Andriotis on the theme of utilizing technology and analytics in cross-border eDiscovery. It's done.The litigation strategies we hear from former judges and cross-border lawyers, and what practical approaches to eDiscovery are easy for judges to understand, may have been useful information for businesses.Participants' particular attention was focused on the need for innovative and efficient solutions to the challenges of information management in eDiscovery.I think that learning about the latest trends in technology used in litigation and information related to eDiscovery litigation not only in the United States but also in Asia was very meaningful for companies. FRONTEO will continue such activities and contribute to the dissemination of useful information for Japanese companies by utilizing the network cultivated through many years of international litigation support and fraud investigation.

Please see the FRONTEO video site FRONTEO Legal Link Portal at a later date to see the pattern of the day.
https://legal.fronteo.com/fllp/dlapiper/movie007

A special interview with Andrew Peck is also introduced in "Legend of AI Utilization, Talking about History and Future" in "Digital Forensic Discovery AI White Paper 2020" published by our company.

https://legal.fronteo.com/fllp/aiwp2020

■FRONTEOabout　URL: https://www.fronteo.com/

FRONTEO uses the in-house developed AI engine "KIBIT" and "concept encoder" specializing in natural language processing to extract meaningful and important information from a huge amount of text data to support corporate business. A data analysis company. Since its establishment in August 2003, it has been expanding globally to Japan, the United States, South Korea, and Taiwan, focusing on legal tech businesses such as "e-discovery (electronic discovery)" and "digital forensic investigation" that support international litigation of companies. Has been deployed.Based on the AI ​​technology cultivated in the legal tech business, we expanded the business field to the life science field, business intelligence field, and economic security from 8, and by using AI to "turn text data into knowledge" , Drug discovery support, dementia diagnosis support, financial / personnel / sales support, etc., contributing to solving various corporate issues. Listed on TSE Mothers on June 2014, 2007. January 6, 26 Obtained a first-class medical device manufacturing and sales license (permit number: 2021B1X13).The capital is 13 thousand yen (as of March 1, 10350).

* FRONTEO, KIBIT, and concept encoder are registered trademarks of FRONTEO in Japan.